Automated mass spectrometry multi-attribute method analyses for process development and characterization of mAbs-Reference-Cited by-同舟云学术

Automated mass spectrometry multi-attribute method analyses for process development and characterization of mAbs

Published:2021-03 Issue: Volume:1166 Page:122540
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Song Yvonne Ehwang,Dubois Hervé,Hoffmann Martin^ORCID,D́Eri Stephen,Fromentin Yann^ORCID,Wiesner Jan^ORCID,Pfenninger Anja,Clavier Séverine^ORCID,Pieper Annette,Duhau Laurent,Roth Udo

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference49 articles.

1. Therapeutic antibodies for autoimmunity and inflammation;Chan;Nat. Rev. Immunol.,2010

2. Monoclonal antibodies: versatile platforms for cancer immunotherapy;Weiner;Nat. Rev. Immunol.,2010

3. Antibodies to watch in 2019;Kaplon;mAbs,2019

4. B. Kelley, Industrialization of mAb production technology: the bioprocessing industry at a crossroads, mAbs 1 (2009) 443–452. https://doi.org/10.4161/mabs.1.5.9448.

5. Juran on quality by design: the new steps for planning quality into goods and services;Juran,1992

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation of a LC-MS based multi-attribute method (MAM) and intact multi-attribute method (iMAM) workflow for the characterisation of a GLP-Fc fusion protein;Analytical Biochemistry;2024-10

2. The Accurate Prediction of Antibody Deamidations by Combining High-Throughput Automated Peptide Mapping and Protein Language Model-Based Deep Learning;Antibodies;2024-09-10

3. Advances and opportunities in process analytical technologies for viral vector manufacturing;Biotechnology Advances;2024-09

4. Mitigating In-Column Artificial Modifications in High-Temperature LC–MS for Bottom–Up Proteomics and Quality Control of Protein Biopharmaceuticals;Analytical Chemistry;2024-08-28

5. Targeted CQA analytical control strategy for commercial antibody products: Replacing ion-exchange chromatography methods for charge heterogeneity with multi-attribute monitoring;mAbs;2024-04-23